147 related articles for article (PubMed ID: 31580884)
21. Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in cynomolgus monkeys.
Enright BP; Compton DR; Collins N; Davis T; McIntyre BS
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):29-39. PubMed ID: 19243028
[TBL] [Abstract][Full Text] [Related]
22. Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia.
Talpaz M; Rakhit A; Rittweger K; O'Brien S; Cortes J; Fettner S; Hooftman L; Kantarjian H
Clin Cancer Res; 2005 Sep; 11(17):6247-55. PubMed ID: 16144928
[TBL] [Abstract][Full Text] [Related]
23. A 9-Month Toxicity and Toxicokinetic Assessment of Subcutaneous Pegylated Human C-peptide (CBX129801) in Cynomolgus Monkeys.
Naas D; Morris T; Kousba A; Mazzoni M
Int J Toxicol; 2015; 34(4):318-24. PubMed ID: 26111539
[TBL] [Abstract][Full Text] [Related]
24. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
Eliason JF; Greway A; Tare N; Inoue T; Bowen S; Dar M; Yamasaki M; Okabe M; Horii I
Stem Cells; 2000; 18(1):40-5. PubMed ID: 10661570
[TBL] [Abstract][Full Text] [Related]
25. Brain Vacuolation Resulting From Administration of the Type II Ampakine CX717 Is An Artifact Related to Molecular Structure and Chemical Reaction With Tissue Fixative Agents.
Purcell R; Lynch G; Gall C; Johnson S; Sheng Z; Stephen MR; Cook J; Garman RH; Jortner B; Bolon B; Radin D; Lippa A
Toxicol Sci; 2018 Apr; 162(2):383-395. PubMed ID: 29253237
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
Baumann A; Tuerck D; Prabhu S; Dickmann L; Sims J
Drug Discov Today; 2014 Oct; 19(10):1623-31. PubMed ID: 24929223
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction.
Baumann A; Piel I; Hucke F; Sandmann S; Hetzel T; Schwarz T
Eur J Pharm Sci; 2019 Mar; 130():11-20. PubMed ID: 30654111
[TBL] [Abstract][Full Text] [Related]
29. Oral repeated-dose toxicity studies of BIA 10-2474 in cynomolgus monkeys.
Weber K; Häcker R; Hardisty JF; Harris SB; Hayes AW
Regul Toxicol Pharmacol; 2020 Mar; 111():104547. PubMed ID: 31816339
[TBL] [Abstract][Full Text] [Related]
30. Subchronic safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis stimulating agent, after 5-week subcutaneous injection in Cynomolgus monkeys and Sprague-Dawley rats.
Gong XL; Zhang XD; Li J; Zhang XF; Zong Y; Lu GC; Yuan BJ
Food Chem Toxicol; 2013 Oct; 60():252-62. PubMed ID: 23911802
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
32. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
[TBL] [Abstract][Full Text] [Related]
33. Final report on the safety assessment of Triethylene Glycol and PEG-4.
Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
[TBL] [Abstract][Full Text] [Related]
34. Quantitative analysis of polyethylene glycol (PEG) and PEGylated proteins in animal tissues by LC-MS/MS coupled with in-source CID.
Gong J; Gu X; Achanzar WE; Chadwick KD; Gan J; Brock BJ; Kishnani NS; Humphreys WG; Iyer RA
Anal Chem; 2014 Aug; 86(15):7642-9. PubMed ID: 25003239
[TBL] [Abstract][Full Text] [Related]
35. Erythropoiesis equivalence, pharmacokinetics and immune response following repeat hematide administration in cynomolgus monkeys.
Woodburn KW; Schatz PJ; Fong KL; Beaumier P
Int J Immunopathol Pharmacol; 2010; 23(1):121-9. PubMed ID: 20378000
[TBL] [Abstract][Full Text] [Related]
36. PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies.
Webster R; Didier E; Harris P; Siegel N; Stadler J; Tilbury L; Smith D
Drug Metab Dispos; 2007 Jan; 35(1):9-16. PubMed ID: 17020954
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic recovery following autologous bone marrow transplantation in a nonhuman primate: effect of variation in treatment schedule with PEG-rHuMGDF.
Farese AM; MacVittie TJ; Roskos L; Stead RB
Stem Cells; 2003; 21(1):79-89. PubMed ID: 12529554
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, tissue distribution and excretion of 40kDa PEG and PEGylated rFVIII (N8-GP) in rats.
Bjørnsdottir I; Sternebring O; Kappers WA; Selvig H; Kornø HT; Kristensen JB; Bagger MA
Eur J Pharm Sci; 2016 May; 87():58-68. PubMed ID: 26517963
[TBL] [Abstract][Full Text] [Related]
39. Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.
Motzer RJ; Rakhit A; Ginsberg M; Rittweger K; Vuky J; Yu R; Fettner S; Hooftman L
J Clin Oncol; 2001 Mar; 19(5):1312-9. PubMed ID: 11230473
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic Vacuolation and Tapetal Changes Induced by a Novel Analgesic Agent in Beagle Dogs.
Takahashi K; Morita Y; Udagawa S; Yamakawa S; Watanabe D; Mutsuga M; Nakajima M; Kohno M; Miyamoto Y; Oshida K
Toxicol Pathol; 2019 Jun; 47(4):494-503. PubMed ID: 30987541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
